Spectranetics (SPNC) Misses Q1 EPS by 7c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Spectranetics Achieves First Quarter 2015 Revenue of $57.4 Million
April 23, 2015 4:03 PM EDTExpands Stellarex Program to Below the Knee Market
Updates 2015 Outlook
COLORADO SPRINGS, Colo., April 23, 2015 (GLOBE NEWSWIRE) -- The Spectranetics Corporation (Nasdaq: SPNC) today reported financial results for the three months ended March 31, 2015. Highlights of the quarter, all compared with the three months ended March 31, 2014 include:
Revenue of $57.4 million, up 45% (47% constant currency1) Vascular Intervention revenue of $36.5 million grew 82% (84% constant currency) U.S. peripheral atherectomy revenue grew 16% AngioSculpt® revenue of $14.0 million achieved Lead Management revenue of $16.4 million increased 14% (16% constant... More


